631-81-2

Basic information

• Product Name: 4-chlorophenyl phenylMethane
• CAS NO: 631-81-2
• Molecular Formula: C13H11Cl
• Molecular Weight: 202.67944
• Mol File: 631-81-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-chlorophenyl phenylMethane(CAS DataBase Reference)
• NIST Chemistry Reference: 4-chlorophenyl phenylMethane(631-81-2)
• EPA Substance Registry System: 4-chlorophenyl phenylMethane(631-81-2)

Safety Data

• Hazardous Substances Data: 631-81-2(Hazardous Substances Data)

Usage

Uses

Used in Chemical Research and Industry:
4-Chlorophenyl phenylmethane is used as a synthetic intermediate for the synthesis of other complex organic compounds. Its unique molecular structure, with the chlorine atom and phenyl group, allows for various chemical reactions and transformations, making it a valuable component in the development of new chemical entities.
Used in Organic Chemistry:
4-Chlorophenyl phenylmethane is used as a reagent in organic chemistry, where its electron-withdrawing chlorine atom and phenyl group can participate in a range of reactions, such as substitution, addition, and elimination reactions. This versatility makes it a useful building block for the synthesis of various organic molecules.
Used in Pharmaceutical Industry:
4-Chlorophenyl phenylmethane is used as a starting material in the synthesis of pharmaceutical compounds. Its molecular structure can be further modified to create new drug candidates with potential therapeutic applications, taking advantage of its reactivity and the presence of the chlorine atom for further functionalization.
Used in Material Science:
4-Chlorophenyl phenylmethane is used as a precursor in the development of new materials, such as polymers and coatings, where its chemical properties can be exploited to create materials with specific characteristics, such as improved stability, reactivity, or functionality.

Upstream product

• 53-16-7 Estrone 

Relevant articles and documents

Synthesis of α-Deuterioalcohols by Single-Electron Umpolung Reductive Deuteration of Carbonyls Using D 2O as Deuterium Source

Deuterium incorporation can effectively stabilize the chiral centers of drug and agrochemical candidates that hampered by rapid in vivo racemization. In this work, the synthetically challenging chiral-center deuteration of alcohols has been achieved via a single-electron umpolung reductive-deuteration protocol using benign D 2O as deuterium source and mild SmI 2as electron donor. The broad scope and excellent functional group tolerance of this method has been showcased by the synthesis of 43 respective α-deuterioalcohols in high yields and ≥98% deuterium incorporations. The potential application of this versatile method has been exemplified in the synthesis of 6 deuterated drug derivatives, 1 deuterated human hormone, and 3 deuterated natural products. This method using D 2O is greener and more efficient compared to traditional pyrophoric-metal-deuteride-mediated reductive deuterations.

Synthetic method of alpha-monodeuterated alcohol compound and deuterated drug

The invention provides an alpha-monodeuterated alcohol compound and a reduction deuteration method of an aldehyde ketone compound for preparing the alpha-monodeuterated alcohol compound. The aldoketone compound shown in a general formula (1) reacts with a divalent lanthanide transition metal compound and a deuterium donor reagent in an organic solvent I to generate the alpha-monodeuterated alcohol compound shown in a general formula (2). The invention establishes a reduction deuteration method of an aldehyde ketone compound based on a single electron transfer reduction deuteration reaction, and the method is used for preparing the alpha-monodeuterated alcohol compound shown in a general formula (2) as well as deuterated derivatives of aldehyde ketone drugs, hormones and natural products of the alpha-deuterated alcohol compounds. The method has the advantages of high product deuteration rate, good regioselectivity, good chemical selectivity, low reagent price, simple operation, mild conditions and wide substrate application range. Compared with an existing H/D exchange method, the deuterium donor reagent is small in dosage, the cost can be remarkably reduced, and the utilization rate of deuterium atoms is increased.

Obtainment of 17β-estradiol or 17β-estradiol-17 α-deuterium through stereoselective reduction of estrone, using NaBH4 and LiBD4 respectively in the presence of a crown ether

The present paper investigates the reduction of estrone 1 to estradiol 2, in methylene chloride in the presence of a crown ether (CE), with solid NaBH4 or LiBD4 in a solid/liquid diphase system. CEs involved in the study were 18-crown-6 (18C6), 15-crown-5 (15C5) and 12-crown-4 (12C4). Our results show that in the case of the reduction process using NaBH4, the 18C6 macrocyclic ligand was the most efficient. The process is stereoselective (leading to 17β-estradiol) being also applied in labelling through deuteration, yielding to 17β-estradiol-17α-deuterium (starting from estrone 1, in the presence of LiBD4 and crown ether 12C4).